Clinical TrialsSearch results
Number of results: 206
Other
- Phase III study of Z-100 in uterine cervix cancer patients
- primary uterine cervix cancer
- ZERIA Pharmaceutical Co.,Ltd.
- 2005-09-13
Other
- A randomized phase III trial of postoperative adjuvant oral fluoropyrimidine vs. sequential paclitaxel / oral fluoropyrimidine; and UFT vs. S1 for T3 / T4 gastric carcinoma: the Stomach Cancer Adjuvant Multi-institutional Trial Group (SAMIT) Trial
- Gastric Cancer
- Young Leaders' Program (YLP), Nagoya University School of Medicine
- 2005-09-01
Other
- Effects of traditional Chinese medicine for chorea in the Huntington's disease.
- Huntington's disease
- Yonezawa National Hospital
- 2008-05-16
Recruiting
- Evaluation of pegaptanib and ranibizumab for macular edema secondary to retinal vein occlusion
- macular edema secondary to retinal vein occlusion
- Yamagata university,Faculty of Medicine
- 2010-04-30
Other
- Anti-VEGF combined with Verteporfin photodynamic therapy in age-related macular degeneration(AMD)
- Age-related Macular Degeneration
- Yamagata University Hospital
- 2009-06-29
Other
- A phase II study of S-1,cisplatin and lentinan in first-line treatment of unresectable or recurrent gastric cancer
- unresectable or recurrent gastric cancer
- Yamagata University Faculty of Medicine Department of Gastroenterological, General, Breast and Thyroid Surgery
- 2009-05-01
Other
- Yamagata Clinical Helicobacter pylori study group
- peptic ulcer
- Yamagata Clinical Helicobacter pylori study group
- 2009-06-17
Other
- The influence of dialyzer membrane on microcirculation and inflammation in hemodialysis patients.
- Chronic renal failure
- Yabuki Hospital
- 2009-06-03
Other
- Randomized phase III study of CPT-11 versus Weekly Paclitaxel for unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum.
- unresectable or recurrent gastric cancer refractory to combination chemotherapy with fluoropyrimidine plus platinum
- West Japan Oncology Group
- 2008-07-15
Other
- A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in R/R DLBCL
- Relapsed/Refractory DLBCL, who have failed or are ineligible for HDT-ASCT
- Vindelov Signe Diness
- 2022-07-25